By Laura Lutz
Washington, Feb. 16 - Fermiscan Holdings Ltd. secured A$22.5 million from a private placement of shares.
The company agreed to sell 15 million ordinary shares to Australian and international institutions and professional and sophisticated investors at A$1.50 per share.
Proceeds will be used for capital expenditures, market development and working capital.
Fermiscan is a Sydney, Australia-based company focused on breast cancer detection.
| Issuer: | Fermiscan Holdings Ltd.
|
| Issue: | Shares
|
| Amount: | A$22.5 million
|
| Shares: | 15 million
|
| Price: | A$1.50
|
| Warrants: | No
|
| Announcement date: | Feb. 16
|
| Stock symbol: | Australia: FER
|
| Stock price: | A$1.695 at close Feb. 16
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
